Literature DB >> 409679

Cytotoxicity of rat macrophages activated by persistent or biodegradable bacterial cell walls.

R J Smialowicz, J H Schwab.   

Abstract

Peritoneal macrophages from Fischer 344 rats were cytotoxic for mouse fibroblasts after in vitro phagocytosis of non-biodegradable group A streptococcal cell walls. In contrast, macrophages from Buffalo rats were not activated to cytotoxicity by bacterial cell walls. Activation to cytotoxicity was only achieved by the macrophages after an interval of at least 3 days in culture after ingestion of group A cell walls. If macrophages were cultured only 24 h after ingestion of cell walls, a cytostatic effect on target cells was observed. Phagocytosis of biodegradable group D streptococcal cell walls did not activate macrophages from either rat strain to become cytotoxic. No direct toxicity of cell walls for macrophages or mouse L-cells was observed. The cytotoxicity of Fischer 344 macrophages appears to require direct cell contact with target cells.

Entities:  

Mesh:

Year:  1977        PMID: 409679      PMCID: PMC421169          DOI: 10.1128/iai.17.3.599-606.1977

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  20 in total

1.  Macrophages activated in vitro with lymphocyte mediators kill neoplastic but not normal cells.

Authors:  W F Piessens; W H Churchill
Journal:  J Immunol       Date:  1975-01       Impact factor: 5.422

2.  Selective cytotoxicity of peritoneal leucocytes for neoplastic cells.

Authors:  O A Holtermann; E Klein; G P Casale
Journal:  Cell Immunol       Date:  1973-12       Impact factor: 4.868

3.  Association of experimental chronic arthritis with the persistence of group A streptococcal cell walls in the articular tissue.

Authors:  J H Schwab; W J Cromartie; S H Ohanian; J G Craddock
Journal:  J Bacteriol       Date:  1967-11       Impact factor: 3.490

4.  Heterocytolysis by macrophages activated by bacillus Calmette-Guérin: lysosome exocytosis into tumor cells.

Authors:  J B Hibbs
Journal:  Science       Date:  1974-04-26       Impact factor: 47.728

5.  Nonspecific macrophage activation by systemic adjuvants. Evaluation by lysosomal enzyme and in vitro tumoricidal activities.

Authors:  M Bruley-Rosset; I Florentin; A M Khalil; G Mathé
Journal:  Int Arch Allergy Appl Immunol       Date:  1976

6.  Processing of streptococcal cell walls by rat macrophages and human monocytes in vitro.

Authors:  R J Smialowicz; J H Schwab
Journal:  Infect Immun       Date:  1977-09       Impact factor: 3.441

7.  Secretion of plasminogen activator by stimulated macrophages.

Authors:  J C Unkeless; S Gordon; E Reich
Journal:  J Exp Med       Date:  1974-04-01       Impact factor: 14.307

8.  Changes in cellular enzyme levels and extracellular release of lysosomal acid hydrolases in macrophages exposed to group A streptococcal cell wall substance.

Authors:  P Davies; R C Page; A C Allison
Journal:  J Exp Med       Date:  1974-05-01       Impact factor: 14.307

9.  Cytostatic elimination of syngeneic rat tumor cells in vitro by nonspecifically activated macrophages.

Authors:  R Keller
Journal:  J Exp Med       Date:  1973-09-01       Impact factor: 14.307

10.  In vitro synthesis and secretion of lysozyme by mononuclear phagocytes.

Authors:  S Gordon; J Todd; Z A Cohn
Journal:  J Exp Med       Date:  1974-05-01       Impact factor: 14.307

View more
  23 in total

1.  Role of Kupffer cells in developing streptococcal cell wall granulomas. Streptococcal cell wall induction of inflammatory cytokines and mediators.

Authors:  C L Manthey; T Kossmann; J B Allen; M L Corcoran; M E Brandes; S M Wahl
Journal:  Am J Pathol       Date:  1992-05       Impact factor: 4.307

2.  Inhibition of macrophage phagocytic activity by group A streptococcal cell walls.

Authors:  R J Smialowicz; J H Schwab
Journal:  Infect Immun       Date:  1978-04       Impact factor: 3.441

3.  Measurement of bacterial cell wall in tissues by solid-phase radioimmunoassay: correlation of distribution and persistence with experimental arthritis in rats.

Authors:  R Eisenberg; A Fox; J J Greenblatt; S K Anderle; W J Cromartie; J H Schwab
Journal:  Infect Immun       Date:  1982-10       Impact factor: 3.441

4.  In vivo changes in complement induced with peptidoglycan-polysaccharide polymers from streptococcal cell walls.

Authors:  J D Lambris; J B Allen; J H Schwab
Journal:  Infect Immun       Date:  1982-01       Impact factor: 3.441

5.  Antibody response to streptococcal cell wall antigens associated with experimental arthritis in rats.

Authors:  J J Greenblatt; N Hunter; J H Schwab
Journal:  Clin Exp Immunol       Date:  1980-12       Impact factor: 4.330

6.  Relationship of complement to experimental arthritis induced in rats with streptococcal cell walls.

Authors:  J H Schwab; J B Allen; S K Anderle; F Dalldorf; R Eisenberg; W J Cromartie
Journal:  Immunology       Date:  1982-05       Impact factor: 7.397

7.  Interaction of group A streptococcal peptidoglycan polysaccharide with human polymorphonuclear leukocytes: implications for pathogenesis of chronic inflammation.

Authors:  P A Leong; J H Schwab; M S Cohen
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

Review 8.  Phlogistic properties of peptidoglycan-polysaccharide polymers from cell walls of pathogenic and normal-flora bacteria which colonize humans.

Authors:  J H Schwab
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

9.  Stimulation of migration of human monocytes by bacterial cell walls and muramyl peptides.

Authors:  T Ogawa; S Kotani; K Fukuda; Y Tsukamoto; M Mori; S Kusumoto; T Shiba
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

10.  Processing of streptococcal cell walls by rat macrophages and human monocytes in vitro.

Authors:  R J Smialowicz; J H Schwab
Journal:  Infect Immun       Date:  1977-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.